All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT secretary
NEW DELHI: All Indian vaccines being developed against the coronavirus will have to be stored at 2-8 degrees Celsius as the logistics have been worked out while considering temperature as a factor,…
Consuming Too Much ‘Kadha’ May Have Adverse Effects
New Delhi : As the world awaits the vaccine for COVID-19, the unprecedented novel Coronavirus continues to rage on. While most lockdown restrictions have been lifted and the country has…
Moderna raises 2021 Covid-19 vaccine output forecast to at least 600 million doses
Moderna Inc said on Monday it would produce at least 600 million doses of its Covid-19 vaccine in 2021, up by 100 million doses from its previous forecast, as the United States continues…
Govt Job for M.Pharm to work in ICMR funded project
The Birla Institute of Technology & Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to “train young men and women able and eager to…
Bharat Biotech Chief Takes On Serum Institute In Vaccine War
Mumbai : A vaccine war has surfaced as India prepares for a massive inoculation drive to prevent the spread of coronavirus, which has killed more than 150,000 in the country. A…
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine
Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D. The company will now be initiating Phase III clinical trial in…
Submitted All Data As Per Guidelines, Says Bharat Biotech
HYDERABAD : Amid concerns over the Indian drug regulator granting emergency use authorisation (EUA) approval to the indigenous Covid-19 vaccine candidate Covaxin even as its Phase 3 trials are underway,…
Govt Job for Ph.D, M.Pharm, M.Sc at NABI
National Agri-Food Biotechnology Institute (NABI) is an autonomous Institute under Department of Biotechnology, Government of India. NABI aims at catalysing the transformation of Agri-food sector in India by being a…
Covishield Gets Approval From DCGI’s Expert Panel
New Delhi : Covishield, the vaccine candidate from Pune-based Serum Institute of India, was approved by a Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) late…
India will have happy New Year with vaccine in hand: DCGI
The drug regulator is currently analysing the data submitted by Serum Institute of India, which is manufacturing Oxford-AstraZeneca vaccine and Bharat Biotech, which is making indigenous vaccine in collaboration with ICMR. The expert panel…
